Investing Profile

Jenny Yip

InvestorVC
Managing Partner at Adjuvant Capital
adjuvantcapital.com/team/San Francisco, California
Photo of Jenny Yip, Managing Partner at Adjuvant Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Adjuvant Capital Managing Partner
$100K - $5.0M
$1.5M
7
$300M
CompanyStageDateRound SizeTotal Raised
Antiva Biosciences
Series EApr 2023$53M
Series DNov 2021$31M
$140M
Co-investors: Wende Hutton (Canaan Partners)
54gene
Convertible NoteOct 2022$50M
Series BSep 2021$25M
Series AApr 2020$15M
$95M
Co-investors: Nathalie Gaveau (Lead Edge Capital), Gabriel Jarrosson
Evofem Biosciences
Post Ipo DebtOct 2020$25M
$75M
Co-investors: Kim P. Kamdar (Domain Associates), Dan Janney (Alta Partners)
ChromaCode
Series CMay 2020$10M
$50M
Co-investors: James Blair (Domain Associates), Justin Klein (Vensana Capital), Charles Petty